The Indian government's slowness to approve booster shots is putting lives at risk - particularly those of front line medical staff whose immunity is waning. HBI speaks to a disappointed operator source in the country to find out more.
Australia's largest oncology provider Icon Group has been bought by EQT's infrastructure arm for AUS$2.4bn. Its CEO Mark Middleton tells HBI that the group now has its sights set on Europe.
Romania's largest healthcare provider Medlife says it has Balkan ambitions while acquiring half of regional oncology provider Neolife. The emergence of pan-EU players continues after the infrastructure investor that earlier bought Medipass, has bought a 14+ clinic network in Germany.
"This is the strongest M&A market I can remember," Hedley Goldberg, managing director at Rothschild & Co told hundreds of attendees at HBI 2021 as he talked about the IPO landscape and how post-COVID M&A is shaping up.
Ageing cobalt-based radiation therapy machines pose a threat to global national security, and moves are afoot by the World Institute for Nuclear Security to see them decommissioned, replaced, and their active elements safely disposed of before they fall into terrorist hands.
Investors and states have ploughed capex into new proton therapy machines across Europe as the machines get smaller, the range of use cases grows and more private insurers start to cover the therapy.
Indian oncology hospital group HealhCare Global Enterprises (HCG) has sold its minority stake in life sciences company Strand after buying in full its oncology lab and clinical trials business.
HBI unpicks where the private sector is winning contracts to help manage sky-high backlogs. Nearly £30bn is up for grabs in elective care, oncology and diagnostics.
The fragmented German radiotherapy market is starting to pique the interest of private equity, as many doctors reach retirement age. Pan-EU platform MedEuropa has acquired a three-centre group in the northwest, and CEO Ralph Hefti tells HBI that its model of co-investing alongside doctors is likely to win out consolidation efforts.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.